PTP4A3 and malignant colon neoplasm: PRL-3 is abundant in many cancer cell lines and metastatic lesions, including gastric cancer [4], malignant melanoma cancer [5], ovarian cancer [6], breast cancer [7], colonic cancer [8] and esophageal squamous cell carcinoma [9].